Paying users zone. Data is hidden behind: .
Get 1-month access to Gilead Sciences Inc. for $17.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Gilead Sciences Inc. pages available today for free:
Price to Book Value (P/BV)
since 2005
Calculation
Gilead Sciences Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Gilead stockholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2018 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2017 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2016 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2015 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2014 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2013 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2012 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2011 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2010 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2009 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2008 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2007 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2006 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2005 | = | ÷ | = | ÷ |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Gilead Sciences Inc.’s Annual Report.
Comparison to Competitors
Gilead Sciences Inc., P/BV, long-term trends, comparison to competitors
| Gilead Sciences Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | ||||||||||||||
| Dec 31, 2018 | ||||||||||||||
| Dec 31, 2017 | ||||||||||||||
| Dec 31, 2016 | ||||||||||||||
| Dec 31, 2015 | ||||||||||||||
| Dec 31, 2014 | ||||||||||||||
| Dec 31, 2013 | ||||||||||||||
| Dec 31, 2012 | ||||||||||||||
| Dec 31, 2011 | ||||||||||||||
| Dec 31, 2010 | ||||||||||||||
| Dec 31, 2009 | ||||||||||||||
| Dec 31, 2008 | ||||||||||||||
| Dec 31, 2007 | ||||||||||||||
| Dec 31, 2006 | ||||||||||||||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Gilead Sciences Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Gilead Sciences Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
Comparison to Industry (Health Care)
Gilead Sciences Inc., P/BV, long-term trends, comparison to industry (health care)
| Gilead Sciences Inc. | Health Care | |
|---|---|---|
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).